PARTHIV SHETH: Open Payments
NPI 1184685877 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 24 payments from 9 companies in 2025. Trend: 2023 $509 · 2024 $550 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $85 |
| Alkermes, Inc. | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| ABBVIE INC. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, FANAPT, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, VRAYLAR, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
